James Chen

James Chen

James Chen — Editor-in-Chief at OwlyTimes, which he founded in 2025 with a small team of editors. Reports on markets with a CPA's suspicion and a reporter's notebook. Came to the project after seven years on a regional business desk in Chicago, where he learned to read footnotes before press releases. Numbers tell stories; he edits the stories so they tell the truth.

1488 articles published

Latest Articles

Tulane’s Pipeline: $5.3K Gap Signals Shift in PrioritiesBusiness

Tulane’s Pipeline: $5.3K Gap Signals Shift in Priorities

Tulane prioritizes business grads—but at what cost? Uncover the $5,300 gap revealing a strategic shift & the impact on vital disciplines. Get the analysis.

San Miguel Traffic Drop: El Mencho's Death Signals Economic StakesFinance

San Miguel Traffic Drop: El Mencho's Death Signals Economic Stakes

El Mencho's death sparked a 15% traffic drop in San Miguel. Discover how this shift reveals deeper economic anxieties and impacts tourism—follow the money!

$1.26B Agritourism Shift: Implications for US FarmsBusiness

$1.26B Agritourism Shift: Implications for US Farms

Uncover the surprising shift reshaping US farms! Our analysis reveals how $1.26B in agritourism signals a vital strategy for survival & growth.

$88M Shift: Quality of Life Now Drives US Job GrowthFinance

$88M Shift: Quality of Life Now Drives US Job Growth

Uncover the surprising force reshaping US jobs! Our analysis reveals how quality of life—not tech—is now driving $88M in growth. Discover the insight.

Trump Tariffs: $15B Trade at Risk – Analysis of the ImpactBusiness

Trump Tariffs: $15B Trade at Risk – Analysis of the Impact

Unravel the chaos: New Trump tariffs threaten $15B in trade. We expose the disconnect between US claims & global realities – and the systemic risks unleashed.

Trump FDA: $3.2B Lobbying Surge Signals Shift in Drug RulesBusiness

Trump FDA: $3.2B Lobbying Surge Signals Shift in Drug Rules

Uncover how a $3.2B lobbying surge is reshaping FDA drug approval. Our analysis reveals a critical shift—and what it means for patient access & costs.

Borman's Exit Signals a Shift in Country Music PowerBusiness

Borman's Exit Signals a Shift in Country Music Power

Uncover the seismic shift in country music! Borman's exit reveals a power struggle—traditional management vs. the algorithm. Gain crucial insight into the ...

US-Mexico Trade: Santander CIB's Nearshoring Impact AnalysisFinance

US-Mexico Trade: Santander CIB's Nearshoring Impact Analysis

Uncover Santander CIB's strategy amid the US-Mexico trade boom! Our analysis reveals how nearshoring fuels demand for advanced financial solutions—and why ...

$62B Shift: Supply Chain Finance's Rising StakesFinance

$62B Shift: Supply Chain Finance's Rising Stakes

Uncover how a $62B shift transforms supply chains! Our analysis reveals why finance is now a critical risk shield & competitive edge for businesses.

$99M in Leases: Baton Rouge Real Estate Signals StrengthFinance

$99M in Leases: Baton Rouge Real Estate Signals Strength

Uncover why Baton Rouge real estate defies national trends! Our analysis reveals a $99M leasing surge & a developer's bold bet—gain crucial market insights.

Tech Price Surge: 170% Chip Cost Signals Wider ImpactBusiness

Tech Price Surge: 170% Chip Cost Signals Wider Impact

Uncover the hidden forces driving tech price hikes! Our analysis reveals how a 170% chip cost surge signals a wider impact & reshapes the industry.

Beard's $83B Shift: DOE Loan Impact & Energy Future StakesFinance

Beard's $83B Shift: DOE Loan Impact & Energy Future Stakes

Uncover the seismic shift in US energy policy! Our analysis reveals how Beard's $83B DOE loan overhaul signals a new era prioritizing reliability & challen...